1-844-989-PATH (7284)
Back
Are there other resources which can help me get access to my medicines if I don’t qualify for the Pfizer PAP?
We encourage patients to consult with their healthcare provider and/or insurance provider to explore the options that best address their healthcare and financial needs. Other resources may be of help (depending on the medicine or vaccines) such as NeedyMeds, RxOutreach (among others), commercial co… Read More
What products will remain within Pfizer PAP as of January 1, 2025?
TypePrimary CareSpecialty CareOncologyMedicinesCelontinDepo-EstradiolDuaveeEstringNorpace CRNurtecPremarinPremphasePremproSynarelTikosynTrecatorZarontinZavzpretBeneFIXCibinqoElelysoEucrisaLitfuloSomavertVelsipityVyndaqel /… Read More
Pfizer RxPathways Updates
.page-node-type-resource-type .node__content .layout:nth-of-type(2) {
background: #fff;
}
.page-node-type-resource-type .node__content .layout:nth-of-type(2):before, .page-node-type-resource-type .node__content .layout:nth-of-type(2):after {
background: #fff;
}
.page-node-type-resource-type .… Read More
Are patients who have commercial insurance eligible for the Pfizer Patient Assistance Program (PAP)?
No. Commercially insured patients (e.g., patients who get their insurance through their job or through a Federal Employer Plan) are not eligible for the PAP.
What products will remain within Pfizer PAP as of January 1, 2026?
TypePrimary CareSpecialty CareOncologyMedicinesCelontinDepo-EstradiolDuaveeEstringNorpace CRNurtecPremarinPremphasePremproTikosynZarontinZavzpretBeneFIXCibinqoElelysoEucrisaLitfuloSomavertVelsipityVyndamaxXeljanz (no new patients starting July 1, 2026)XynthaBesponsaBosulif (no new patients starting… Read More
Why is Pfizer adding this new requirement for patients enrolled in a Medicare Part D/Medicare Advantage Plan in 2025?
Beginning in 2025 the benefit changes outlined in the Inflation Reduction Act will help many Medicare Part D/Medicare Advantage patients, including (1) the reduction of out-of-pocket prescription costs for covered medicines to $2,100 annually and (2) a voluntary option for enrollment in the… Read More